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Summary
CD4+ T helper (Th) clones can be divided into interleukin 2 (IL2)-secreting Thl and IIr4-
secreting Th2 cells . We show in the present report that these two Th subsets have different
activation requirements for lymphokine production and proliferation : namely, cholera toxin (CT)
as well as forskolin inhibit T cell receptor (TCR)-mediated IL2 production and proliferation
inThl cells, while the same reagents fail to block 114 production and proliferation in Th2 cells .
In addition, CT and forskolin differentially influence the proto-oncogene mRNA expression
in Thl vs . Th2 cells after stimulation with Con A . Since both reagents lead to elevated levels
ofintracellular cAMP, it is likely that Thl and Th2 cells differ in their sensitivity to an increase
in CAMP. Our results indicate that thetwo Th subsets use different transmission signal pathways
upon TCR-mediated activation .
M
ature T cells are functionally specialized for recogni-
tion of antigen in the context ofMHC gene products
(1) . They can be divided into class I-restricted CD8' cyto-
toxic cells and class II-restricted CD4+ Th cells (2) . Re-
cently, in the murine system, two types ofCD4+ Th cells
have been described that differ in their autocrine growth factor
and other lymphokine production. Namely, Th type I cells
(Thl) make IL2 and IFN-y, and Th type II cells (Th2) se-
crete 11,4, 11,5, and IL6 upon activation (for review, see ref-
erence 3) . In addition, onlyTh2 cells are high expressors of
the80-kD I1L1-R, which has recently been cloned (4) . While
both types of cells are able to help B cells to secrete anti-
bodies, the nature of this help is quite different . IL4 induces
selective isotype switching to IgG1, IgE, and IgA, while IFN-y
counteracts IL4 and leads to IgG2a secretion (5) . In addi-
tion, 114 increases class II expression onB cells, while IFN-y
blocks that induction (6) .
Several lines ofevidence indicate that the two types ofcells
use different pathways to transmit signals from the cell sur-
face to the nucleus in response to mitogenic activation (7) .
We have described recently thatTh2 cells are less dependent
on protein kinase C (PKC)t activation than Thl cells (7a) .
We have continued our comparison of signal transmission
pathways in activated Thl vs. Th2 cells, and we have estab-
lished anew distinction between the two types ofhelper cells.
We report here that cholera toxin (CT), which ribosylates
the cY subunit of the G stimulatory protein, G5, resulting
in accumulation o£ intracellularcAMP (8), inhibits c,fos and
' Abbreviations used in thispaper. CT, cholera toxin ; PKC, protein kinaseC.
c-mycmRNA expression, IL2 production, and proliferation
in Thl cells in response to TCR-mediated triggering. On
the other hand, the same doses of this toxin do not block
IL4 production and proliferation in Th2 cells. It is likely that
the selective inhibitory effect of CT on Thl vs . Th2 cells
is due to their differential sensitivity to high levels ofcAMP,
since administration of forskolin, which is a direct activator
of the adenylate cyclase, leading to accumulation of CAMP,
produces a similar pattern oflymphokine secretion and prolifer-
ation in the two types of cells .
Materials and Methods
Mice
￿
BALB/c (H-2d) and AKR/J (H-2k) mice were purchased
from Taconic (Germantown, NY) .
Media andReagents.
￿
Complete culture medium wasRPMI 1640
(Gibco Laboratories, Grand Island, NY) supplemented with 2mM
t-glutamine (Gibco Laboratories), 1 mM Hepes, 50mM 2-ME an-
tibiotics (Gibco Laboratories), and 10% FCS (HyClone Laborato-
ries, Logan, UT) . u-[31P]dCTP (800 Ci/mmol) was purchased
fromNew England Nuclear (Boston, MA) . All other reagents were
from Sigma Chemical Co. (St . Louis, MO) .
Cell Lines.
￿
The generation and maintenance of the cloned Th2
cell lines D10.G4.1(D10) (American Type Culture Collection, Rock-
ville, MD) (specific for conalbumin in the context of I-A"),
CDC.25 (specific for rabbit IgG in the context of I-A'), and the
Thl cell line D1.5 (identical specificity as CDC.25) have been de-
scribed (9-11) . Briefly, Th cell lines were stimulated every 2 wk
with antigen and irradiated syngeneic splenocytes asAPC . tx-Methyl
mannoside-containing supernatant from rat spleen cells that had
been stimulated with Con A for 48 h was added to the culture
medium as a source of lymphokines. For the IL2 and 11,4 bioas-
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response to either lymphokine .
Proliferation and Lymphokine Assays.
￿
Proliferative responses of
theT cell clones were assessed by purifying live cells on a Ficoll-
Paque gradient (Pharmacia Fine Chemicals, Piscataway, NJ) at least
2 wk after restimulation with antigen and irradiated spleen cells .
Usually, 2.5 x 105/mlT cells were cultured in 200-pl aliquots in
the presence ofmAb1452C11 (2C11, anti-CD3, used as20% tissue
culture supernatant) plus or minusILl (1 ng/ml) in 96-well plates .
PMA was used at 10 ng/ml, and ionomycin at 0.5 ug/ml. rII,2
was used at 5 U/ml. For the CT experiments, resting T cells
(106/ml) were incubated in RPMI 1640 at 37°C for 2 h with the
indicated doses ofthe toxin. The cells were then washed three times
with complete medium andused for proliferation assays as described
above . The cultures were incubated for 60 h at 37°C, and
[3H]TdR (0 .5 F,Ci/well) was added for the final 12 h of culture.
Radioactivity incorporated into DNAwasmeasured by liquid scin-
tillation counting .
To determine the lymphokine activity secreted by the stimu-
lated T cell clones, supernatants were collected after a24-h culture
and assessed in a bioassay on the HT-2 indicator cell line. Briefly,
2 x 10" HT-2 cells/well were incubated with 25% supernatant for
24 h (final volume 200 liters/well) .DNA synthesis was measured
by theMTT method, as previously described (12) .
RNA Analysis .
￿
Except for the time course experiment, resting
T cells were stimulated withConA(5 lAg/ml) for 60 min for cfos
mRNA expression and with ConA or IIL1 (1 ng/ml) for 150 min
for c-myc and c-mybmRNA expression . Total RNA was then ex-
tracted as described elsewhere (13), with some modifications . Briefly,
10' cells were washed three times with cold PBS, pelleted, and
resuspended in 3 ml of 3M LiCI/6 M urea. The suspension was
homogenizedwith a 60-s pulse using a polytron . TheRNA was
then precipitated at 4°C for 15 h and extracted twice with
phenol/chloroform/isoamylalcohol . 20 p,g ofRNA was subjected
to electrophoresis on a Northern gel (1% agarose/2% formalde-
hyde/1x MOPS) andthe gel blotted onto a nylonmembrane (Bio-
trans Nylon membrane ; ICN, Irvine, CA) . TheRNAwas cross-
linked according to the protocol developedby Church and Gilbert
(14) . The blot was prehybridized in 5% SDS, 100mM NaCl, 50
mM sodium phosphate, and 1 mM EDTA for 2 h at 65°C, and
then hybridized for 12 h in a new aliquot of the same solution,
containing an ot-[32]P random primed probe. The hybridized mem-
brane was washed three times for 5mineach at 65°C in 5% SDS,
1x SSC, and three times for 30 min each at 65°C in 0.1% SDS,
0.5x SSC. Autoradiographs were exposed at -70°C with enhancer
screens.
Q4antitation ofcAMP Levels.
￿
Resting cells (106/ml) were in-
cubated with CT for 1 h or forskolin for 30 min at 37°C . The
reaction wasstoppedby adding 5ml coldPBS . The cells were spun
down and resuspended in 0.5 ml 10mM Tris-HCl, pH 7.4, 1mM
MgCl 2 , andsonicated for30 s . Ice-cold TCA was added to a final
concentration of 6%, and the suspension was kept on ice for 30
min. After centrifugation at 13,000 rpm for 15 min, the superna-
tant was collected and extracted four times with 4 vol of H20-
saturated diethylether to remove the remaining TCA. The level
ofcAMP was determined using an RIA kit (Amersham Corp .,
Arlington Heights, IL).
DNA Probes .
￿
ThefollowingDNAs were used for the prepara-
tion of random primed probes (kit from Boehringer Mannheim
Biochemicals, Mannheim,FRG) .cfos is an EcoRI/SstlcDNA frag-
ment ; c-myc is a genomic BamHI/Xba I fragment ; c-myb is a
genomicEcoRl fragment ; and 0-actin is a Pstl cDNA fragment.
All plasmids were obtained from American Type Culture Collection.
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Results
Differential Sensitivity of T Cell Subsets to Cholera Toxin
Cholera Toxin Inhibits Thi Cell Proliferation Induced by TLR-
mediated Stimulation, but not by IL2 . It has been reported
thatCT has an inhibitory effect on mitogen-induced prolifer-
ation in peripheral T cells, as well as in T cell clones (15) .
To test the effect ofCT in aprototypeThl clone, we pretreated
D1.5 cells with various doses of toxin. The cells were then
stimulated with IL2, anti-CD3 (2C11), or PMAplus iono-
mycin . The two latter reagents mimic TCItmediated stim-
ulation (16) . As can be seen in Fig. 1 A, the proliferation
induced by 2C11 or PMA plus ionomycin is almost com-
pletely inhibited by 0.01 Ag/ml CT, while the response to
IL2 is unaffected.
To test whether theinhibitory effect ofCT on the prolifer-
ation of D1.5 cells is related to the accumulation ofCAMP,
we measured the proliferation of this clone in the presence
of increasing doses of forskolin . Fig. 1 B shows a dose-
dependent inhibition ofT cell proliferation in response to
Figure 1 .
￿
Proliferation of D1 .5 cells is inhibited by CT and by for-
skolin. Resting cells were pretreated with several doses of CT (A), or
cultured in the presence of increasing doses of forskohn (B), and
stimulated with soluble anti-CD3 (145201) mAb or IL2, as de-
scribed in Materials and Methods. Results are expressed as percentage
13H]TdR incorporation compared with control cells that were stimu-
lated in the absence of CT or forskolin . The following cpm were ob-
tained in control cells : 11.2, 112,692 t 15,702; 1452C11, 17,688 ±
556 ; PMA plus ionomycin, 20,999 t 7,199 ; none, 347 t 133 . One
representative out of three independent experiments is shown .PMA plus ionomycin, while, again, the response to exoge-
nous 11,2 is unaffected . Similar results were obtained with
the cAMP analogue 8-Br-CAMP (data not shown) .
Cholera Toxin Does not Inhibit MR-mediated Proliferation in
Th2 Cells. - It has been suggested that Thi and Th2 cells
use different transmission signaling pathways after TCR-
mediated stimulation (7) . Furthermore, the regulation of their
respective autocrine growth factors is quite different (7a) . To
test the effect ofCT on the proliferation of Th2 cells, we
pretreated D10 cells with several doses of CT, before stimu-
lation with anti-CD3 . As shown in Fig. 2A, no inhibition
was detected, even with high doses (5 p,g/ ml) of the toxin .
Similar results were obtained with the Th2 clone CDC25 .
A 50-fold higher dose ofCT than was used in Thl cells (0.01
compared with0.5 Fog/ml) was ineffective to block prolifera-
tion in these cells . In an additional experiment, even higher
Figure 2 .
￿
Proliferation of Th2 cells in the presence of CT or for-
skolin. (A) Resting D10 cells were pretreated with several doses of
CT and stimulated with soluble anti-CD3 mAb plus ILI, as de-
scribed in Materials and Methods . (B) Resting CDC25 cells were
stimulated as D10 cells in the presence of increasing doses of for-
skolin. The following cpm were obtained in control cells : (A) un-
stimulated D10 cells, 1,304 t 106; D10 cells stimulated with anti-
CD3 + ILl, 70,489 t 9,598 . (B) unstimulated CDC25 cells, 335
t 129 ; CDC25 cells stimulated with anti-CD3 + ILI, 32,649 t
732 ; CDC25 cells stimulated with 11,2, 50,157 t 3,345 . One repre-
sentative out of three independent experiments is shown .
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doses of CT (0.1-1 Ag/ml) were tested and failed to inhibit
TCR-mediated proliferation in this clone (data not shown) .
Again, to check the effect of CAMP on the proliferative re-
sponse of these cells, forskolin was included in these experi-
ments . As shown in Fig . 2 B, a dose of 25 P,M forskolin was
required to induce 40% inhibition of proliferation . This
represents a 50-fold higher dose than the one used to induce
an85% inhibition in the proliferation ofThl cells, mediated
by PMA plus ionomycin . It is possible that 25 p,m forskolin
is slightly toxic for the cells, because this dose also inhibited
the proliferative response of Th2 cells mediated by exoge-
nous IIr2 (Fig . 2) .
Cholera Toxin and ForskolinBlock 11,2 Production in Thl Cells,
but not 11,4 Production in Th2 Cells. The inhibitory effect
ofCT and forskolin on the proliferative response of the Thl
clone D1.5 suggests that these agents block the secretion of
the autocrine growth factor IL2, because the addition of ex-
ogenous 1172 restores proliferation . It is possible, however,
that the autocrine growth factor IL4 is released in stimu-
lated Th2 cells in the presence ofCT or forskolin . As can
be seen in Fig. 3, this is the case. No inhibition ofIL4 produc-
tion was seen in anti-CD3-stimulated CDC25 cells in the
presence ofCT or forskolin . Identical results were obtained
in D10 cells (data not shown) . In contrast, the Thl clone.
D1.5 failed to secrete IL2 when stimulated in the presence
of CT or forskolin (Fig. 3, A and B) .
Cholera Toxin and Forskolin Increase the LevelofIntracellular
CAMP in Th2Cells. A previous report, as well as the results
presented in this paper, indicates that the inhibition ofprolifer-
ation mediated byCT in Thl cells is likely due to an increase
in the level of intracellular CAMP (15) . One important step
in this process is the ribosylation in the a subunit of a G,
protein (8, 17) . The inability ofCT to inhibit proliferation
in activatedTh2 cells could be explained by a missing G pro-
tein target of CT. Nevertheless, as we show in Fig. 4, both
CT and forskolin were able to induce a significant increase
in the level of intracellular CAMP in D10 (Fig. 4 A) as well
as in CDC25 (Fig . 4 B) cells . Total values of CAMP fluctu-
ated from experiment to experiment, but in all five tests, treat-
ment with forskolin or CT lead to significant increases in
the level of CAMP in comparison with untreated cells.
Cholera Toxin Induces c-myb Expression, but Inhibits cfos and
c-mpc mRNA in Con A-activated Thl Cells. As shown in
Fig. 1, CT and forskolin block the proliferation ofD1.5 cells
in response to TCItmediated activation . It was of interest,
therefore, to analyze the effect of these agents on the proto-
oncogene expression in these cells. Resting cells were incubated
with CT for 2 h, washed, and recultured in the presence or
absence ofConA (514g/ml) . TotalRNA was then extracted
at different timepoints in order to evaluate steady state mes-
sage levels of the c-myb, cfos, and c-myc genes . As can be
seen in Fig. 5 A, Con A andCT independently induced c-myb
mRNA, and this expressionwas not affected when both agents
were added together, orwhen CT was replaced by forskolin .
In contrast, CT did not induce c-mw and c-fos mRNA on
itsown (Fig. 5, A and B), but blocked the expression of these
proto-oncogenes induced by Con A . It is likely that this in-r
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Figure 3 .
￿
Lymphokine production by TCR-stimulated Thl and
Th2 cells in the presence ofCT or forskolin. D1 .5 (Thl, l1r2 pro-
ducer) and CDC25 (Th2, 11,4 producer) cells were either pretreated
with CT (A) or cultured in the presence of forskolin (B). All cells
were stimulated with soluble anti-CD3 mAb (145201) for 24 h .
After this time, 100 p.l of supernatant was removed and tested for
lymphokine content on the HT-2 indicator cell line . The following
values were obtained in control cells : unstimulated CDC25 cells, 0;
CDC25 cells stimulated with anti-CD3 mAb, 0.206 ± 0.017; un-
stimulated D1 .5 cells, 0.004 t 0.002 ; D1.5 cells stimulated with
anti-CD3 mAb, 0.122 t 0.007 .
hibition is due to the increase in the level ofintracellular CAMP,
because Con A-induced c-mycmRNA was also inhibited by
forskolin (Fig . 5A) . The induction ofc-fosmRNA byPMA
was also blocked by CT (Fig. 5 B) .
Proto-Oncogene Expression in Th2 Cells after ConA Stimula-
tion . The expression of proto-oncogenes during T cell
proliferation has been extensively studied (18, 19) . It is thought
that the induction of some of these genes is required for the
progression of the cell cycle (20) . cfos, c-myc, and c-myb are
transcribed after TCR-mediated stimulation or in response
to other stimuli such as lymphokines (21, 22) . It was, there-
fore, of interest to determine the expression of these proto-
oncogenes in activated Th2 cells . For this purpose, resting
D10 cells were stimulated with Con A (5 14g/ml), which
has been shown to bind and precipitate TCR proteins (23)
and to activate T cells through the TCR. Total RNA was
extracted at different timepoints thereafter. As can be seen
Differential Sensitivity ofT Cell Subsets to Cholera Toxin
Figure 4 .
￿
CT and forskolin induce accumulation of intracellular
cAMP. (A) Resting D10 cells were treated with: unstimulated (a),
0 .5 Fcg/ml CT (b), 1 ug/ml CT (c), 10 uM forskolin (d), and 25 IM
forskolin (e) . (B) Resting CDC25 cells were treated with : unstimu-
lated (a), 0 .1 ug/ml CT (b), 0.5 hg/ml CT (c), and 1 wg/ml CT (d) .
CAMP was measured as indicated in Materials and Methods.
in Fig . 6, c;fosmRNA peaked at 1 h, while c-myb and c-myc
mRNA were also detected in these cells and peaked at 2 and
3 h after activation, respectively. Thus, Th2 cells seem to have
a similar profile of proto-oncogene expression as peripheral
T cells (24) .
Cholera Toxin Induces c-myb Expression and Inhibits c-m
￿
but
not c.fos mRNA in Con A-activated Th2 Cells.
￿
As sown
above, CT blocks neither 114 production nor proliferation
in Th2 cells after TCR-mediated activation. Since this agent
inhibits c-myc and cfos expression in stimulated Thl cells,
we studied its effect on the proto-oncogenemRNA expres-
sion in activated Th2 cells . Resting Th2 cells were stimu-
lated with Con A, as described above for Thl cells, and total
RNA was extracted at the indicated timepoints. As shown
in Fig . 7 A, the profile of proto-oncogene mRNA expres-Figure 5.
￿
CT inhibits cfos and c-m)v mRNA expression in Con
A-activated D1.5 cells. (A) Resting cells were activated for 2.5 h
under the following conditions : unstimulated (lane 1) ; ConA (lane
2) ; Con A plus 1 ug/ml CT (lane 3); Con A plus 10 WM forskolin
(lane 4) ; 1 FAg/ml CT (lane 5). (B) Resting cells were activated for
1 h under the following conditions: unstimulated (lane 1) ; Con A
(lane 2) ; PMA (lane 3); ConA plus 1 pg/ml CT (lane 4) ; PMA plus
1 ug/ml CT (lane 5); 1 ftg/ml CT (lane 6) .
sion is very similar in activated D10 as in Thl cells . Again,
CT induces c-myb mRNA on its own, and inhibits Con A-in-
duced c-myc expression . Identical inhibition is seen with for-
skolin . These two agents, however, do not influenceCon A-in-
duced cfos expression, in contrast to what was found inThl
cells. The same results were obtained with CDC25 cells
(Fig. 8) .
Ilrl Induces c-myc mRNA in Th2 Cells, and this Expression
Is not Affected by C.T ., Forskolin, or 8-BrcAMP It has been
reported that only Th2, but not Thl, cells express the re-
cently cloned Ilrl-R (25), indicating a dependence of Th2
cells on this lymphokine . Thus, we analyzed the effect of
IM on the proto-oncogenemRNA expression in Th2 cells.
As can be seen in Fig. 9, IIA induces c-mycmRNA expres-
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Figure 6 .
￿
Time course of proto-oncogene mRNA expression in
Con A-activated D10 cells . Resting cells were stimulated with Con
A and total RNA was extracted at different time points thereafter.
sion in D10 cells . In contrast to what we observed in Con
A-activated Th2 cells, however, IIA-induced c-myc expres-
sion is not inhibited by pretreatment with CT forskolin, or
8-Br CAMP (Fig. 9) . These results suggest that c-myc expres-
sion in Th2 cells can be achieved by at least two different
transmission signaling pathways.
Discussion
The activation ofT cells by specific antigen, mitogen, or
mAb directed against TCR structures induces the hydrolysis
of phosphatidylinositol 4'5' biphosphate, which is mediated
by phospholipase C (26) . This hydrolysis leads to the produc-
tion of second messengers, such as diacylglycerol and ino-
sitol triphosphate. DAG can activate the enzyme PKC (27),
while InSP3 increases the concentration of intracellular cal-
cium (28) . It is believed that these second messengers lead
to increased levels of proto-oncogenemRNA, production of
lymphokines, expression of lymphokine receptors, and cel-
lular proliferation (29) . Another system ofsecond messengers
is related to the adenylate cyclase pathway. Activation of this
enzyme leads to accumulation of intracellular CAMP, which
can activate a CAMP-dependent kinase (30) . Increased levels
ofCAMP have been described in T cells in response to TCR-
mediated stimulation (reviewed in reference 31) and in re-
sponse to I1J1 (32) . The PKC- and the CAMP-dependent ki-
nase pathways interact in certain cell systems (33) .Figure 7 .
￿
CT inhibits c-mw but not cfos mRNA expression in
Con A-activated D10 cells. (A) Resting D10 cells were stimulated for
2 .5 h under the following conditions : unstimulated (lane 1) ; 1 Ag/ml
CT (lane 2) ; Con A (lane 3) ; Con A plus 1 Ag/ml CT (lane 4) ; and
Con A plus 25 AM forskolin (lane 5) . (B) Resting D10 cells were
stimulated for 1 h under the following conditions : unstimulated (lane
1) ; 1 Ag/ml CT (lane 2); 25 AM forskolin (lane 3) ; 1 Ag/ml CT
plus Con A (lane 4); and Con A plus 25 AM forskolin (lane 5) .
The role ofcAMP as second messenger in T cells is con-
troversial . There are many inducible genes that can be tran-
scribed in response to cAMP. These include genes that con-
tain a consensus sequence in the promoter that has been named
cAMP-RE (CAMP response element) (34) . On the other hand,
elevated levels of CAMP are inhibitory for the proliferation
of peripheral T cells, as well as for T cell clones (15, 35) .
Interestingly, as has been reported (35) and we show here,
CT blocks the proliferation ofThl cells induced with anti-
TCR antibody or PMA plus ionomycin, but not with exog-
enous IIr2 . This inhibition is probably mediated through in-
creased levels of intracellularCAMP and is selective to stimuli
that activate PKC . These results are in contrast to those
reported by Farrar et al . (36), who found that in the CT6
cytotoxic T cell line, an increase in the level of intracellular
cAMP blocked proliferation and c-myc expression in response
to IIS2 . It is important to note that in this cell line, the inter-
action of IIr2 with the IIJ2-R leads to translocation ofPKC
from the cytosol to the membrane (37), which does not happen
in other T cells (38-40) . In theThl cells that we tested, CT
was unable to block c-myc expression induced by exogenous
IIr2 (E . Mufioz, A. Zubiaga, and BT Huber, unpublished
results), but inhibited c-myc and cfos mRNA expression in-
duced either by Con A or PMA.
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Figure 8 .
￿
CT inhibits c-myc but not cfos mRNA expression in
Con A-activated CDC25 cells. (A) Resting cells were stimulated for
2 .5 h under the following conditions: unstimulated (lane 1); Con A
(lane 2) ; Con A plus 1 Ag/ml CT (lane 3) ; Con A plus 25 AM for-
skolin (lane 4) ; and 1 Ag/ml CT (lane 5) . (B) Resting cells were
stimulated for 1 h under the following conditions : unstimulated (lane
1) ; Con A (lane 2) ; Con A plus 0 .1 Fcg/ml CT (lane 3) ; Con A plus
0 .5 Ag/ml CT (lane 4) ; Con A plus 1 Ag/ml CT (lane 5) ; Con A
plus 1 AM forskolin (lane 6) ; Con A plus 10 AM forskolin (lane 7) ;
and Con A plus 25 AM forskolin (lane 8) .
Our present report shows that TCR-mediated prolifera-
tion in Th2 cells is not affected by CT, whereas Thl cells
are inhibited . This raises the possibility that Th2 cells do not
use PKC as a major signal transmission pathway after TCR-
mediated stimulation . In fact, we have previously shown that
Figure 9 .
￿
IL-1-induced c-myc mRNA expression is not affected by
CT, forskolin, or 8-Br CAMP. Resting D10 cells were stimulated for
2 .5 h under the following conditions : unstimulated (lane 1) ; 1 kg/ml
CT (lane 2) ; 25 PM forskolin (lane 3) ; 1 ng/ml ILI (lane 4) ; 1
ng/ml IL-1 plus 1 Ag/ml CT (lane 5) ; 1 ng/ml IL-1 plus 25 AM for-
skolin (lane 6) ; and 1 ng/ml ILl plus 1 mM 8-Br cAMP (lane 8) .Th2 cellscan respond to antigenic stimulation in the absence
of functional PKC (7a). In addition, Th2 cells are dependent
on IIA for proliferation (41), and we have shown recently
that ILl induces high levels of intracellular cAMP in these
cells (32). Therefore, while CAMP may be inhibitory in Thl
cells, it could be important for activation and proliferation
in Th2 cells.
Some proto-oncogenes are known to encode proteins that
act as transcription factors: e.g., cfos and cjun, which form
an AP-1 binding heterodimer necessary for IL2 gene tran-
scription (42). Indeed, it has been confirmed that activation
of the IL2 gene requires de novo protein synthesis (43). We
show here that CT and forskolin inhibit cfos mRNA ex-
pression induced by Con A in Thl cells. It is possible, there-
fore, that blocking ofcfos constitutes the mechanism of the
CT-mediated inhibition of IL2 production. In contrast, in
Th2 cells that release 114 as autocrine growth factor, cfos
mRNA induction is not affected by CT
c-myb and c-myc have been shown to play a role in T cell
proliferation induced by mitogens (44, 45) . c-myb also seems
to be important in T cell proliferation triggered by exoge-
nous IL2 (22), but probably requires the coexpression ofc-
myc for full T cell activation to occur. This is based on the
results reported here, namely, that Th2 cells that accumulate
c-myb, but not c-mer, mRNA after incubation with forskoln
or CT, fail to proliferate rate in response to these agents. As shown
in Fig. 9, exogenous ILl can provide the signal required for
the induction ofc-myc expression that is not affected by CT
Of interest is the fact that IL1 can induce c-myc mRNA by
a PKC-independent pathway (Munoz, E., A. Zubiaga and
BT Huber, manuscript submitted for publication). This could
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the moment whether the findings in long-term in vitro
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PKC pathway is the major system of activation in Thl cells,
different second messengers that are still unknown are gener-
ated in Th2 cells after activation.
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